Diversified Consumer Services
Company Overview of Johns Hopkins University
Johns Hopkins University is an educational institution that offers undergraduate, graduate, part-time, summer, and distance education programs in the arts and music, humanities, social and natural sciences, engineering, international studies, education, business, and the health professions. Johns Hopkins University was incorporated in 1867 and is based in Baltimore, Maryland.
3400 North Charles Street
Baltimore, MD 21218-2683
Founded in 1867
Key Executives for Johns Hopkins University
Executive Director of Communications and Public Affairs
Vice President of Communications and Public Affairs
Director of Alumni Relations
Compensation as of Fiscal Year 2015.
Johns Hopkins University Key Developments
Johns Hopkins University LLC Wins $1.17 Million Task Order
Oct 3 15
Johns Hopkins University LLC won a $1,167,008 task order from the U.S. Department of Defense for the technical analysis of strategic strike capabilities.
Johns Hopkins University Presents at Alliance for Regenerative Medicine Stem Cell Meeting on the Mesa, Oct-08-2015 05:45 PM
Oct 2 15
Johns Hopkins University Presents at Alliance for Regenerative Medicine Stem Cell Meeting on the Mesa, Oct-08-2015 05:45 PM. Venue: Estancia La Jolla Hotel & Spa, 9700 North Torrey Pines Road, La Jolla, CA 92037, United States. Speakers: Jennifer Elisseeff, Director, Translational Tissue Engineering Center.
Progenics Pharmaceuticals Enters into Licensing Agreement with Johns Hopkins
Aug 13 15
Progenics Pharmaceuticals Inc. has entered into an exclusive worldwide licensing agreement with Johns Hopkins University for 18F-DCFPyL, or PyL, a clinical-stage prostate specific membrane antigen, or PSMA, targeted imaging agent for prostate cancer. PyL, when used in conjunction with high-resolution PET imaging, has shown potential for use in identifying prostate cancer and sites of relapse. PyL was developed by a team led by Martin G. Pomper, M.D., Ph.D. at the Johns Hopkins University School of Medicine. An early stage clinical trial of PyL with PET imaging in men with prostate cancer demonstrated uptake of PyL in sites of putative metastatic disease and primary tumors not seen with currently approved imaging techniques, suggesting the potential for high sensitivity and specificity in detecting prostate cancer.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|